Alkem Laboratories unit to acquire majority stake in Swiss firm Occlutech for 99 million euros
Alkem Laboratories announced Friday its medical device unit will buy a 55 percent stake in Swiss firm Occlutech. The deal is worth nearly 100 million euros.
Insights:
Alkem Laboratories Limited announced on February 13, 2026, that its medical devices unit will acquire a stake of up to 55% in Switzerland 
CH-based Occlutech Holding. The transaction involves a total consideration of €99.4 million. This significant investment by the India 
IN-based company represents a major cross-border acquisition within the medical technology sector.
CH-based Occlutech Holding. The transaction involves a total consideration of €99.4 million. This significant investment by the India IN-based company represents a major cross-border acquisition within the medical technology sector.The announced deal is set to alter the ownership structure of Occlutech Holding by transferring up to a 55% stake to the Alkem Laboratories medical devices unit. As a sizable cross-border merger and acquisition, the €99.4 million transaction highlights a notable expansion of Alkem's footprint in the international medical devices market.
